The second cycle of negotiations will take place under President Donald Trump's administration. The U.S. government has said ...
21h
TipRanks on MSNInnovent Biologics’ SYCUME® Gains Approval as China’s First IGF-1R Antibody for Thyroid Eye DiseaseAn announcement from Innovent Biologics ( ($HK:1801) ) is now available. Innovent Biologics has announced the approval of SYCUME®, China’s first ...
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to ...
Contributor Content In his years as Director of Surgical Neuro-Oncology at the University of Southern California (USC), Dr. Thomas Chen has witnessed countless innovations in the world of cancer ...
Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of ...
Harvey CEO Winston Weinberg recently chatted with one of the startup's investors, Sarah Guo, on her podcast "No Priors" about ...
IHCL is aiming to double its portfolio by 2030 and grow its international presence in markets that host Indian diaspora.
President Donald Trump is hosting Ireland's prime minister, Micheál Martin, for the annual St. Patrick's Day celebration at ...
Harley-Davidson (NYSE:HOG) fell on Wednesday after the European Union said it would impose counter-tariffs on 26 billion ...
The integration of the businesses will expand Constantia Flexibles' range of packaging solutions.
Alex Scharfman's A24 movie 'Death of a Unicorn' mixes 'Knives Out' and 'Jurassic Park' for a toothless big pharma satire.
The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9%, reaching US$66.59 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results